Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
News|Articles|May 22, 2026

You Can Build AI In-House. But Should You?

Author(s)EVERSANA
Whitepapers

Related Content

Building a Patient-Centric Commercial Model in the AI Era

ByCourier Health
July 23rd 2026

What if patient onboarding evolved alongside today's therapies?

ByNoble
July 16th 2026

The Connected Patient Ecosystem

ByNoble
July 16th 2026

Human Factors is more than a regulatory requirement. It is a competitive advantage.

ByNoble
July 16th 2026

The First Dose Is Everything.

ByNoble
July 16th 2026

Trending on PharmExec

1

FDA Pannel Votes to Loosen Restrictions for Four Peptides

2

Pharmaceutical Executive Daily: FDA Votes to Reduce Restrictions on Four Peptides

3

The Business Case for Employer-Based GLP-1 Coverage

4

President Trump Announces Phased Generic Drug Tariff Plan: Report

5

Healthcare on the Ballot: The 2026 Midterm Elections

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us